These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25549357)

  • 1. EZH2 regulates cofilin activity and colon cancer cell migration by targeting ITGA2 gene.
    Ferraro A; Boni T; Pintzas A
    PLoS One; 2014; 9(12):e115276. PubMed ID: 25549357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells.
    Ferraro A; Mourtzoukou D; Kosmidou V; Avlonitis S; Kontogeorgos G; Zografos G; Pintzas A
    Int J Biochem Cell Biol; 2013 Feb; 45(2):243-54. PubMed ID: 23116973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
    Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
    Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
    Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
    BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
    Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
    J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
    Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
    Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer.
    Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway.
    Wei FZ; Cao Z; Wang X; Wang H; Cai MY; Li T; Hattori N; Wang D; Du Y; Song B; Cao LL; Shen C; Wang L; Wang H; Yang Y; Xie D; Wang F; Ushijima T; Zhao Y; Zhu WG
    Autophagy; 2015; 11(12):2309-22. PubMed ID: 26735435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cofilin overexpression affects actin cytoskeleton organization and migration of human colon adenocarcinoma cells.
    Popow-Woźniak A; Mazur AJ; Mannherz HG; Malicka-Błaszkiewicz M; Nowak D
    Histochem Cell Biol; 2012 Nov; 138(5):725-36. PubMed ID: 22790341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression.
    Xu L; Deng Q; Pan Y; Peng M; Wang X; Song L; Xiao M; Wang Z
    Int J Mol Med; 2014 Jan; 33(1):91-6. PubMed ID: 24212330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.
    Estornes Y; Gay F; Gevrey JC; Navoizat S; Nejjari M; Scoazec JY; Chayvialle JA; Saurin JC; Abello J
    Int J Cancer; 2007 Nov; 121(10):2162-71. PubMed ID: 17583572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
    Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
    Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone methyltransferase EZH2 as cancer treatment.
    Kondo Y
    J Biochem; 2014 Nov; 156(5):249-57. PubMed ID: 25179367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of a recombinant shRNA expression vector targeting EZH2 gene and its inhibitory effect on colon adenocarcinoma SW480 cells].
    Wang JX; Lü YF; Han BB
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):730-3. PubMed ID: 23291064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.
    Kikuchi J; Koyama D; Wada T; Izumi T; Hofgaard PO; Bogen B; Furukawa Y
    J Clin Invest; 2015 Oct; 125(12):4375-90. PubMed ID: 26517694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin.
    Gunawan M; Venkatesan N; Loh JT; Wong JF; Berger H; Neo WH; Li LY; La Win MK; Yau YH; Guo T; See PC; Yamazaki S; Chin KC; Gingras AR; Shochat SG; Ng LG; Sze SK; Ginhoux F; Su IH
    Nat Immunol; 2015 May; 16(5):505-16. PubMed ID: 25751747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
    Wu J; Crowe DL
    Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.
    Crea F; Fornaro L; Bocci G; Sun L; Farrar WL; Falcone A; Danesi R
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):753-61. PubMed ID: 22711031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.